Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
CBT Pharmaceuticals (Australia) Pty Ltd.
Scientific Title
A Phase 1/2 Dose Escalation and Expansion Study of Combination CBT-501 or Nivolumab With CBT-101 in Locally Advanced or Metastatic Hepatocellular and Renal Cell Carcinoma